Angiotensin II inhibits long-term potentiation within the lateral nucleus of the amygdala through AT1 receptors

Peptides

Volumn 19, Issue 6, 1998, Pages 1031-1036

  Von Bohlen Und Halbach, Oliver ^a   Albrecht, Doris ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Amygdala; Angiotensin II; Extracellular; In vitro; Long term potentiation; Rats

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; SARALASIN;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RECEPTOR INTERACTION; LEARNING; LONG TERM POTENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AMYGDALA; ANGIOTENSIN II; ANIMALS; ELECTROPHYSIOLOGY; FEMALE; IMIDAZOLES; LONG-TERM POTENTIATION; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

ANIMALIA;

EID: 0031826709     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00044-8     Document Type: Article

References (44)

1. Abe, K.; Watanabe, Y.; Saito, H. Differential role of nitric oxide in long-term potentiation in the medial and lateral amygdala. Eur. J. Pharmacol. 297:43-46; 1996.
2. Adolphs, R.; Tranel, D.; Damasio, H.; Damasio, A. Impaired recognition of emotion in facial expression following bilateral damage to the human amygdala. Nature (London). 372:669-672; 1994.
3. Aggleton, J. P. The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss; 1992.
4. Albrecht, D.; Broser, M.; Krüger, H.; Bader, M. Effects of angiotensin II and IV on lateral geniculate neurons in non-transgenic and TGR(mREN2)27 transgenic rats. Eur. J. Pharmacol. 332:53-63; 1997.
5. Amouyel, P.; Richard, F.; Cottel, D.; Amant, C.; Codron, V.; Helbecque, N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:203-205; 1996.
6. Armstrong, D. L.; Garcia, E. A.; Ma, T.; Quinones, B.; Wayner, M. J. Angiotensin-II blockade of long-term potentiation at the perforant path-granule cell synapse in-vitro. Peptides. 17:689-693; 1996.
7. Barnes, J. M.; Barnes, N. M.; Costall, B.; Coughlan, J.; Kelly, M. E.; Naylor, R. J.; Tomkins, D. M.; Williams, T. J. Angiotensin-converting enzyme inhibition, angiotensin, and cognition. J. Cardiovasc. Pharmacol. 19 (Suppl):63-71; 1992.
8. Barnes, J. M.; Barnes, N. M.; Costall, B.; Horovitz, Z. P.; Ironside, J. W.; Naylor, R. J.; Williams, T. J. Angiotensin II inhibits cortical cholinergic function: implications for cognition. J. Cardiovasc. Pharmacol. 16:234-238; 1990.
9. Bliss, T. V.; Douglas, R. M.; Errington, M. L.; Lynch, M. A. Correlation between long-term potentiation and release of endogenous amino acids from dentate gyrus of anaesthetized rats. J. Physiol. Lond. 377:391-408; 1986.
10. Burns, L. H.; Everitt, B. J.; Robbins, T. W. Intraamygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 impairs acquisition but not performance of discriminated approach to an appetitive CS. Behav. Neural Biol. 61:242-250; 1994.
11. Chapman, P. F.; Bellavance, L. L. Induction of long-term potentiation in the basolateral amygdala does not depend on NMDA receptor activation. Synapse. 11:310-318; 1992.
12. Chapman, P. F.; Kairiss, E. W.; Keenan, C. L.; Brown, T. H. Long-term synaptic potentiation in the amygdala. Synapse. 6:271-278; 1990.
13. Croog, S. H.; Levine, S.; Testa, M. A.; Brown, B.; Bulpitt, C. J.; Jenkins, C. D.; Klerman, G. L.; Williams, G. H. The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 314:1657-1664; 1986.
14. Denny, J. B.; Polan Curtain, J.; Wayner, M. J.; Armstrong, D. L. Angiotensin II blocks hippocampal long-term potentiation. Brain Res. 567:321-324; 1991.
15. Gean, P. W.; Chang, F. C.; Huang, C. C.; Lin, J. H.; Way, L. J. Long-term enhancement of EPSP and NMDA receptor-mediated synaptic transmission in the amygdala. Brain Res. Bull. 31:7-11; 1993.
16. Gean, P. W.; Chang, F. C.; Huang, C. C.; Lin, J. H.; Way, L. J. Long-term enhancement of EPSP and NMDA receptor-mediated synaptic transmission in the amygdala. Brain Res. Bull. 31:7-11; 1993.
17. Gean, P. W.; Chang, F. C.; Hung, C. R. Use-dependent modification of a slow NMDA receptor-mediated synaptic potential in rat amygdala slices. J. Neurosci. Res. 34:635-641; 1993.
18. Govantes, C.; Marin, J. Effect of angiotensin converting enzyme inhibitors on quality of life in hypertensive patients. Pharmacodynamic basis. Fundam. Clin. Pharmacol. 10:400-405; 1996.
19. Greenland, K.; Wyse, B.; Sernia, C. Identification and characterization of angiotensin-IV binding-sites in rat neuron and astrocyte cell-cultures. J. Neuroendocrinol. 8:687-693; 1996.
20. Izquierdo, I. Pharmacological evidence for a role of long-term potentiation in memory. FASEB J. 8:1139-1145; 1994.
21. Johnston, C. I. Biochemistry and pharmacology of the renin-angiotensin system. Drugs. 39:21-31; 1990.
22. LeDoux, J. E. Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2:191-197; 1992.
23. Lee, E. H. Y.; Ma, Y. L.; Wayner, M. J.; Armstrong, D. L. Impaired retention by angiotensin-II mediated by the AT(1) receptor. Peptides. 16:1069-1071; 1995.
24. Maren, S.; Fanselow, M. S. Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J. Neurosci. 15:7548-7564; 1995.
25. Martinez, J. L.; Derrick, B. E. Long-term potentiation and learning. Annu. Rev. Psychol. 47:173-203:173-203; 1996.
26. Metzenauer, P.; Barnes, N. M.; Costall, B.; Gozlan, H.; Hamon, M.; Kelly, M. E.; Murphy, D. A.; Naylor, R. J.; Barnes, J. M.; Barber, P. C. Identification of angiotensin II receptor subtypes in human brain. Cognitive enhancing actions of PD123177 detected in a mouse habituation paradigm. Neuroreport. 2:351-353; 1991.
27. Mooney, R. D.; Zhang, Y.; Rhoades, R. W. Effects of angiotensin II on visual neurons in the superficial laminae of the hamster's superior colliculus. Vis. Neurosci. 11:1163-1173; 1994.
28. Morimoto, K.; Katayama, K.; Inoue, K.; Sato, K. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol. Biochem. Behav. 40:893-899; 1991.
29. Phillips, M. I. Functions of angiotensin in the central nervous system. Ann. Rev. Physiol. 49:413-434; 1987.
30. Rogan, M. T.; LeDoux, J. E. LTP is accompanied by commensurate enhancement of auditory-evoked responses in a fear conditioning circuit. Neuron. 15:127-136; 1995.
31. Saavedra, J. M. Brain and pituitary angiotensin. Endocr. Rev. 13:329-380; 1992.
32. Scott, S. K.; Young, A. W.; Calder, A. J.; Hellawell, D. J.; Aggleton, J. P.; Johnson, M. Impaired auditory recognition of fear and anger following bilateral amygdala lesions. Nature (London). 385:254-257; 1997.
33. Shindou, T.; Watanabe, S.; Yamamoto, K.; Nakanishi, H. NMDA receptor-dependent formation of long-term potentiation in the rat medial amygdala neuron in an in vitro slice preparation. Brain Res. Bull. 31:667-672; 1993.
34. Smith, R. D.; Chiu, A. T.; Wong, P. C.; Herblin, W. F.; Timmermans, P. B. M. W. M. Pharmacology of non-peptide angiotensin II receptor antagonists. Pharmacol. Rev. Pharmacol. Toxicol. 32:135-165; 1992.
35. Sumners, C.; Raizada, M. K.; Kang, J.; Lu, D.; Posner, P. Receptor-mediated effects of angiotensin-II on neurons. Front. Neuroendocrinol. 15:203-230; 1994.
36. Vallotton, M. B. The renin-angiotensin system. Trends. Pharmacol. Sci. 8:69-74; 1987.
37. von Bohlen und Halbach, O.; Albrecht, D. Visualization of specific angiotensin II binding sites in the rat limbic system. Neuropeptides. 32:241-245; 1998.
38. von Bohlen und Halbach, O.; Albrecht, D. Mapping of angiotensin AT1 receptors in the limbic system of rats. Reg. Pept. (submitted) 1998.
39. A, NMDA and muscarinic receptors in induction of long-term potentiation in the medial and lateral amygdala in vitro. Neurosci. Res. 21:317-322; 1995.
40. Wayner, M. J.; Armstrong, D. L.; Polan Curtain, J. L.; Denny, J. B. Ethanol and diazepam inhibition of hippocampal LTP is mediated by angiotensin II and AT1 receptors. Peptides. 14: 441-444; 1993.
41. Wayner, M. J.; Polan Curtain, J.; Armstrong, D. L. Angiotensin AII AT1 receptor mediates ethanol-diazepam inhibition of hippocampal LTP. Clin. J. Physiol. 37:55-61; 1994.
42. Wayner, M. J.; Polan Curtain, J.; Armstrong, D. L. Dose and time dependency of angiotensin II inhibition of hippocampal long-term potentiation. Peptides. 16:1079-1082; 1995.
43. Wright, J. W.; Harding, J. W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18:21-53; 1994.
44. Xiong, H.; Marshall, K. C. Angiotensin II depresses glutamate depolarizations and excitatory postsynaptic potentials in locus coeruleus through angiotensin II subtype 2 receptors. Neuroscience. 62:163-175; 1994.